Company intelligence / Profile preview

CuraScript

Lake Mary, Florida, United States

Ownership: Private
Employees: ~33000
Development stage: Other

Overview

CuraScript is a leading specialty pharmaceutical distributor in the U.S., providing commercial-stage distribution services for a wide range of therapies, including oncology, immunology, neurology, and other chronic and rare diseases, but it does not conduct its own clinical trials or generate clinical data.

Modalities: Small moleculeMonoclonal antibodyBiologicDevice
Industry: Non-Academic Healthcare

Partnerships

Janssen BiotechActelion Pharmaceuticals (Janssen/Johnson & Johnson)Multiple pharmaceutical manufacturers via authorized distribution

Beyond the preview

Go deeper on CuraScript.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CuraScript.

Explore the full profile